PPARGC1A and metabolic dysfunction-associated steatohepatitis: Importantly, we found a positive correlation between the hepatic expression of PGC-1α and SIRT2 in human NASH patients, where NASH patients exhibited synergistically lowered PGC-1α and SIRT2 expression compared to healthy controls (Fig. 4D).